Trial Details

COMPLETED
Basic Information
Clinical ID c3924
Identifier NCT01316718
Trial Title Mesalazine for the Treatment of Diarrhoea-predominant Irritable Bowel Syndrome (IBS-D)
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Irritable Bowel Syndrome With Diarrhoea
Interventions DRUG: Mesalazine|DRUG: Placebo
Participant Information
Sponsor University of Nottingham
City Notts
Country/Region United Kingdom
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE4
Time Information
Start Date 2011-03
Primary Completion Date 2013-09
Completion Date 2013-09